Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Moligand™, ≥98%(HPLC) Moligand™ ベースライン干渉を最小限に抑える必要がある、感度の高いクロマトグラフィーおよび分析ワークフロー向け。
Room temperature Normal に出荷。正確な仕様については、ロット固有の COA をご確認ください。
SDS、COA、データシート、仕様書をダウンロードできます。ロット固有の COA はロット番号検索で入手可能です。
クロマトグラフィー、有機合成、クロスカップリング反応に関する 12 件の査読済み論文で引用されています。
Carprofen inhibits canine COX2 with IC50 of 30 nM.
危険性、取扱い、保管、および規制遵守を網羅した包括的な文書。
<<<<<<< HEAD SDS をダウンロード → ======= SDS をダウンロード → >>>>>>> release248-p3Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| 分類 | Indoles and derivatives |
| Subclass | Carbazoles |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Carbazoles |
| Alternative Parents | Indoles Benzenoids Aryl chlorides Pyrroles Heteroaromatic compounds Monocarboxylic acids and derivatives Carboxylic acids Azacyclic compounds Organopnictogen compounds Organonitrogen compounds Organochlorides Organic oxides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Carbazole - Indole - Aryl chloride - Aryl halide - Benzenoid - Pyrrole - Heteroaromatic compound - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Azacycle - Organochloride - Organohalogen compound - Organic oxygen compound - Organic oxide - Organic nitrogen compound - Carbonyl group - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organopnictogen compound - Aromatic heteropolycyclic compound |
| 説明 | This compound belongs to the class of organic compounds known as carbazoles. These are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. |
| External Descriptors | organochlorine compound - carbazoles |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | 日付 | 商品 |
|---|---|---|---|
| Certificate of Analysis | Oct 09, 2026 | C153919 | |
| Certificate of Analysis | Aug 29, 2026 | C153919 | |
| Certificate of Analysis | Aug 04, 2026 | C153919 | |
| Certificate of Analysis | Aug 04, 2026 | C153919 | |
| Certificate of Analysis | Aug 04, 2026 | C153919 | |
| Certificate of Analysis | Nov 04, 2025 | C153919 | |
| Certificate of Analysis | Mar 04, 2025 | C153919 | |
| Certificate of Analysis | Aug 05, 2022 | C153919 | |
| Certificate of Analysis | Aug 05, 2022 | C153919 | |
| Certificate of Analysis | Aug 05, 2022 | C153919 | |
| Certificate of Analysis | Aug 05, 2022 | C153919 |
| 溶解度 | Soluble in Methanol |
|---|---|
| 融点(°C) | 200 °C |
| 分子量 | 273.710 g/mol |
| XLogP3 | 4.000 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 273.056 Da |
| Monoisotopic Mass | 273.056 Da |
| Topological Polar Surface Area | 53.100 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 362.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Tested application types, recommended dilutions, and validated procedural steps are not specified for this item. Refer to the CoA/Spec Sheet and SDS for any item-specific instructions.
General reminders (non-specific):
If you require application-specific guidance, please contact Technical Support with details of your use case.
General biochemical context (literature; not a statement of use for this specific product):
Important notes:
Carprofen is not a buffering reagent. However, buffer considerations are important for its use in biochemical assays due to its poor water solubility.
Practical guidance (general):
Not typically applicable:
Item-specific buffer recipes or validated conditions: Not specified for this item; refer to CoA/Spec Sheet.
While Carprofen itself is the target compound rather than a solvent or reagent, greener choices can be made in its handling, dissolution, and derivatization workflows.
Dissolution and assay preparation (general):
Synthetic transformations (general):
Comparison of solvent choices (illustrative; not product specifications):
DMSO vs Ethanol/Buffer
Waste and lifecycle considerations:
Item-specific environmental metrics (e.g., LCA, solvent residuals): Not specified for this item; refer to CoA/Spec Sheet.
This section addresses formulation and manufacturing context without therapeutic claims.
Reference material and QC (general):
Formulation considerations (general):
Regulatory notes:
Item-specific pharmacopeial status, residual solvent compliance, and excipient compatibility: Not specified for this item; refer to CoA/Spec Sheet.
Research Use Note: For research use only. No clinical or diagnostic applications are supported for this catalog item.
Item-specific physico-chemical specifications (e.g., exact melting range, water content, residual solvents) are not provided for this catalog entry. Consult the CoA/Spec Sheet for definitive values.
Literature/general reference values (for context; not product specifications):
Practical notes (general):
Item-specific values not specified for this item; refer to CoA/Spec Sheet.
Grade supplied: Moligand™ (item-specific). This designation is used by Aladdin Scientific to indicate material positioned for use as a molecular ligand, tool compound, or reference standard in discovery workflows (e.g., biophysical binding assays, screening, and chemical biology). It emphasizes identity, consistency, and suitability as a small-molecule probe rather than chromatographic solvent performance.
What Moligand™ typically implies (general):
Item-specific analytical specifications (if any):
Practical implications for users:
As a well-characterized carbazole-derived propionic acid, carprofen serves primarily as a small-molecule tool compound and reference standard in discovery and analytical workflows. It also functions as a versatile synthetic substrate due to its carboxylic acid, aryl chloride, and carbazole motifs.
Research applications (general, non-clinical):
Synthetic applications (general):
Practical tips:
General literature guidance for common derivatizations of Carprofen (not product specifications; optimize per substrate and scale):
Amide couplings:
Esterification:
Acid chloride formation:
Cross-coupling at aryl chloride (where feasible with this scaffold):
Practical notes:
Item-specific optimal conditions or yields: Not specified for this item; refer to CoA/Spec Sheet.
Item-specific GHS classification and hazard statements are not provided for this listing. Always consult the product SDS for authoritative safety information.
General safety guidance (non-specific, good laboratory practice):
Research Use Note: For research use only.
Carprofen is a lipophilic aromatic carboxylic acid with very low water solubility at neutral pH and good solubility in polar aprotic organics.
Polarity and miscibility (literature/general):
Practical guidance:
Selection versus alternatives:
Item-specific solvent compatibility or UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.
Item-specific storage and shipping:
General storage guidance (good practice):
Reconstitution (general suggestions):
Stability notes:
Item-specific stability data (shelf life, solution stability, degradation pathways) and reconstitution concentrations: Not specified for this item; refer to CoA/Spec Sheet.
Carprofen is a chloro-substituted carbazole-derived propionic acid, commonly encountered as a racemic mixture.
Item-specific identifiers (from Product Data)
Literature structural identifiers (for reference; not product specifications)
Structural features (general chemistry description)
Carprofen’s functionality enables diverse derivatizations for SAR libraries and materials-like conjugates.
Transformations of the carboxylic acid:
Aryl chloride diversification:
Nitrogen chemistry:
Stereochemical considerations:
Retrosynthetic value:
Item-specific biological target data (e.g., named targets, binding constants, selectivity across isoforms) are not provided for this catalog entry.
General note (literature; not product specification): Carprofen is frequently used as a reference inhibitor in cyclooxygenase enzymology. However, quantitative specificity parameters are assay- and enantiomer-dependent and should be sourced from primary literature for the exact system under study.
For authoritative information on any validated targets associated with this specific lot or grade, please consult the CoA/Spec Sheet or contact Technical Support.
当社のグレード選定ガイドでは、カタログ内のすべてのバリエーションについて、純度、安定剤の状態、用途への適合性を網羅しています。
Moligand™ グレードガイドを見る →